Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06383871
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-25
First Post:
2024-04-19
Brief Title:
A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour
Sponsor:
Shandong Suncadia Medicine Co Ltd
Organization:
Shandong Suncadia Medicine Co Ltd
Study Overview
Official Title:
An Open Multicenter Phase I Study of Safety Tolerability Pharmacokinetics and Efficacy of HRS-7058 Monotherapy in Patients With Advanced Solid Tumour With KRAS G12C Mutation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multicentre open phase I clinical study of dose escalation dose extension and efficacy extension of HRS-7058 in subjects with advanced malignant tumour To evaluate the safety tolerability pharmacokinetics and efficacy of HRS-7058
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None